In people with type 2 diabetes at high cardiovascular risk, 104 weeks of treatment with tirzepatide was associated with reduced albuminuria and a slower decline in eGFR compared with treatment with insulin glargine
Ordered a lot of shots and never disappointed Great product
The therapeutic benefits including appetite suppression, improved glycaemic control, and any weight loss effects will gradually diminish over the subsequent weeks as drug concentrations decline
Endogenous glucagon-like peptide-1 reduces drinking behavior and is differentially engaged by water and food intakes in rats
As the skin stretches to accommodate excess fat, it often loses elasticity, causing unsightly sagging, wrinkling, and other concerns
Reconstituted solutions should be stored at 2-8C